Is your organization missing from this list? Reach out to Simran Lamba, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: slamba@mjhlifesciences.com
Fixed-Duration Mosunetuzumab/Polatuzumab Active in R/R MCL
Zidesamtinib Active, Safe in Pretreated ROS1+ Advanced NSCLC
Mosunetuzumab/Polatuzumab Vedotin Triples PFS in LBCL
Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care